Pulmonary Multi-drug Resistant Tuberculosis

Also known as: Tuberculosis, Pulmonary, Multi Drug-resistant / Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) / Pulmonary multidrug-resistant tuberculosis

Drug	Drug Name	Drug Description
DB08903	Bedaquiline	A diarylquinoline antimycobacterial used in combination with other antibacterials to treat pulmonary multidrug resistant tuberculosis (MDR-TB).
DB11637	Delamanid	An antibiotic used to treat multidrug resistant tuberculosis.

Drug	Drug Name	Target	Type
DB08903	Bedaquiline	Cytochrome P450 3A4	enzyme
DB08903	Bedaquiline	ATP synthase subunit c	target
DB08903	Bedaquiline	Serum albumin	carrier
DB08903	Bedaquiline	Alpha-1-acid glycoprotein 1	carrier
DB11637	Delamanid	Deazaflavin-dependent nitroreductase	enzyme
DB11637	Delamanid	Cytochrome P450 3A4	enzyme
DB11637	Delamanid	Serum albumin	carrier
DB11637	Delamanid	Alpha-1-acid glycoprotein 1	carrier

Drug	Drug Name	Phase	Status	Count
DB00330	Ethambutol	3	Completed	1
DB00951	Isoniazid	3	Completed	1
DB00218	Moxifloxacin	3	Completed	1
DB05154	Pretomanid	3	Completed	1
DB00339	Pyrazinamide	3	Completed	1
DB01045	Rifampicin	3	Completed	1
DB08903	Bedaquiline	Not Available	Completed	1